Postdoctoral Scientists in Immunotherapies, NYC

Overview

New postdoctoral scientist positions are open to work on our newly discovered immune checkpoint pathways including
1) basic studies in mechanisms;
2) translational immunotherapies in diseases. Our lab focuses on new immune checkpoint pathways and novel immunotherapies from fundamental discoveries to novel drugs to clinical trials. More information can be found on our lab website: xingxingzanglab.org. Some of our publications include Nat Commun. 15:11, 2024; 13:2506, 2022;
Sci Adv. 10:eadk
1857, 2024; 8:eabm
7012, 2022;
Clin Cancer Res. 30:865, 2024; 27:2636, 2021;
Cell Mol Immunol. 20:694, 2023;
Dev Cell 58:2700, 2023; J Clin Invest. 132:e163620, 2022;
Sci Immunol. 6:eabf
9792, 2021.

• Conduct basic studies to investigate mechanisms of immune checkpoint pathways.
• Advance translational immunotherapies in diseases, progressing from fundamental discoveries to novel drugs and clinical trials.

• Preference for candidates with at least one first author publication in reputable scientific journals.

The lab is well funded. The pay scale is higher than NIH guidelines (approximately $65,000 with adjustment for more senior candidates).

Apply information and contact details are not included here as part of the job content; please refer to official communications for application procedures.

Albert Einstein College of Medicine is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran or disabled status, or genetic information. Einstein seeks candidates whose skills and personal and professional experience have prepared them to contribute to our campus and the communities we serve.